Orthocell appoints exclusive UK distributor for Remplir
Orthocell (ASX:OCC) has appointed LEDA Orthopaedics as the exclusive distributor for its flagship collagen nerve wrap, Remplir, across the United Kingdom.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Orthocell (ASX:OCC) has appointed LEDA Orthopaedics as the exclusive distributor for its flagship collagen nerve wrap, Remplir, across the United Kingdom.
Strata Minerals (ASX:SMX) announced the imminent recommencement of drilling at its 100%-owned Zelica Gold Project in Western Australia.
North Stawell Minerals (ASX:NSM) has commenced a 2,000–2,500-metre air core drilling program at its Caledonia and Darlington projects.
Imugene (ASX:IMU) announced exceptional clinical data from the CAR T-naïve cohort of its ongoing Phase 1b basket study of azer-cel.
Clarity Pharmaceuticals (ASX:CU6) has exceeded recruitment targets for its registrational Phase 3 AMPLIFY trial in just nine months.
Lode Resources (ASX:LDR) commenced a high-priority, 32-hole drilling program at its flagship Uralla Gold Project.
Franco-Nevada (NYSE:FNV), the gold-focused royalty and streaming company, reported record-breaking financial results for the fiscal year ended December 31, 2025.
Laser Photonics (NASDAQ:LASE), a leading industrial developer of high-power laser systems for cleaning and material processing, announced preliminary, unaudited financial results for the fiscal year ended December 31, 2025.
Ideal Power (NASDAQ:IPWR), the pioneer behind the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reported fourth-quarter and full-year 2025 financial results on Tuesday.
ADC Therapeutics (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation antibody-drug conjugates (ADCs), reported a steady fourth quarter for 2025 and a significantly strengthened balance sheet on Tuesday.